Abstract:Despite recent insights gained from the effects of targeted deletion of the Finkel-Biskis-Jinkins osteosarcoma oncogene (c-fos), Spleen focus-forming virus (SFFV) proviral integration 1 (PU.1), microphthalmia- associated transcription factor, NF-kappa B, and nuclear factor of activated cells cytoplasmic 1 (NFATc1) transcription factor genes, the mechanism underlying transcription factors specifying osteoclast (OC) lineage commitment from monocyte/macrophage remains unclear. To characterize the mechanism by which transcription factors regulate OC lineage commitment, we mapped the critical cis-regulatory element in the promoter of cathepsin K (Ctsk), which is expressed specifically in OCs, and found that CCAAT/enhancer binding protein alpha (C/EBP alpha) is the critical cis-regulatory element binding protein. Our results indicate that C/EBP alpha is highly expressed in pre-OCs and OCs. The combined presence of macrophage colony-stimulating factor and receptor activator of NF-kappa B ligand significantly induces high C/EBP alpha expression. Furthermore, C/EBP alpha(-/-) newborn mice exhibited impaired osteoclastogenesis, and a severe osteopetrotic phenotype, but unaffected monocyte/macrophage development. Impaired osteoclastogenesis of C/EBP alpha(-/-) mouse bone marrow cells can be rescued by c-fos overexpression. Ectopic expression of C/EBP alpha in mouse bone marrow cells and monocyte/ macrophage cells, in the absence of receptor activator of NF-kappa B ligand, induces expression of receptor activator of NF-kappa B, c-fos, Nfatc1, and Ctsk, and it reprograms monocyte/ macrophage cells to OC-like cells. Our results demonstrate that C/EBP alpha directly up-regulates c-fos expression. C/EBP alpha(+/-) mice exhibit an increase in bone density compared with C/EBP alpha(+/+) controls. These discoveries establish C/EBP alpha as the key transcriptional regulator of OC lineage commitment, providing a unique therapeutic target for diseases of excessive bone resorption, such as osteoporosis and arthritis.

Research progresses of transcription factor CCAAT enhancer binding protein α

Progress of Transcription Factor CCAAT Enhancer Binding Protein Β

Advances in the Research of Human CCAAT/Enhancer-binding Protein Ε

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Critical Role for CCAAT/Enhancer-Binding Protein Β in Immune Complex-Induced Acute Lung Injury

CCAAT/enhancer-binding Protein Δ is a Critical Mediator of Lipopolysaccharide-Induced Acute Lung Injury.

Post-translational Modification of Transcription Factor C/EBPβ

Upregulation of C/EBPα Contributes to Colorectal Cancer Growth, Metastasis and Indicates Poor Survival Outcome.

P300/cyclic adenosine monophosphate response element binding protein and its biological functions

Transcriptional Regulation of Adipocyte Differentiation: A Central Role for CCAAT/Enhancer-binding Protein (C/EBP) β

Progress on Roles and Mechanisms of CCAAT/enhancer Binding Protein Β in Endometrium Decidualization

Genome-Wide Phylogenetic Analysis, Expression Pattern, and Transcriptional Regulatory Network of the Pig C/EBP Gene Family

The CCAAT/Enhancer-Binding Protein Family: Its Roles in MDSC Expansion and Function

CCAAT/enhancer-binding Protein Α Antagonizes Transcriptional Activity of Hypoxia-Inducible Factor 1 Α with Direct Protein–protein Interaction

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

Repression of Transcription Mediated by Dual Elements in the CCAAT/enhancer Binding Protein Α Gene

C/EBP‐α, Involvement of a Novel Transcription Factor in Leptin‐induced VCAM‐1 Production in Mouse Chondrocytes

The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control

C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting Β-Catenin

Role of the CCAAT Enhancer Binding Proteins (c/ebps) in Adipocyte Differentiation

Role of C/EBP alpha in adipocyte differentiation